![Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study](https://www.spandidos-publications.com/article_images/ol/18/4/ol-18-04-4136-g02.jpg)
Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
![Thermal distribution and response in Q-switched ruby laser treatment for oculodermal melanosis (Nevus of Ota) Thermal distribution and response in Q-switched ruby laser treatment for oculodermal melanosis (Nevus of Ota)](https://oaepublishstorage.blob.core.windows.net/066a5fe7-c745-433f-b4f8-83a1b2824c47/1761.fig.2.png)
Thermal distribution and response in Q-switched ruby laser treatment for oculodermal melanosis (Nevus of Ota)
![Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial - Journal of the American Academy of Dermatology Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial - Journal of the American Academy of Dermatology](https://www.jaad.org/cms/asset/f402f4bf-37eb-4970-a02a-591c791af817/gr1.jpg)
Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial - Journal of the American Academy of Dermatology
![Cosmetics | Free Full-Text | Comparative Efficacy of Fractional CO2 Laser and Q-Switched Nd:YAG Laser in Combination Therapy with Tranexamic Acid in Refractory Melasma: Results of a Prospective Clinical Trial Cosmetics | Free Full-Text | Comparative Efficacy of Fractional CO2 Laser and Q-Switched Nd:YAG Laser in Combination Therapy with Tranexamic Acid in Refractory Melasma: Results of a Prospective Clinical Trial](https://pub.mdpi-res.com/cosmetics/cosmetics-08-00037/article_deploy/html/images/cosmetics-08-00037-g002.png?1620896634)